Equities
  • Price (EUR)21.60
  • Today's Change-0.20 / -0.92%
  • Shares traded0.00
  • 1 Year change-30.37%
  • Beta--
Data delayed at least 15 minutes, as of Aug 11 2022 11:10 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Victrex plc is a United Kingdom-based company, which manufactures and sells polymers worldwide. The Company develops polyetheretherketone (PEEK) and PAEK polymer solutions, and semi-finished and finished parts. The Company also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities. The Company operates through two segments: Industrial and Medical. The Industrial segment is focused on the Company’s energy and industrial, value-added resellers (VAR), automotive, aerospace and electronics markets. The Medical segment is focused on providing specialist solutions for medical device manufacturers. The Company’s subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component, Manufacturing Limited and Juvora Limited.

  • Revenue in GBP (TTM)321.60m
  • Net income in GBP70.30m
  • Incorporated1993
  • Employees895.00
  • Location
    Victrex PLCVictrex Technology Centre, Hillhouse International,THORNTON CLEVELEYS FY5 4QDUnited KingdomGBR
  • Phone+44 125 389 7700
  • Fax+44 125 389 7701
  • Websitehttp://www.victrexplc.com/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.